<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "potassium chloride in sodium chloride 0.9% inj BAG">
<dose><value>200</value>
<value>500</value>
</dose><route><value>IV</value>
</route><form><value>inj BAG</value>
</form><drugname><value>potassium chloride in sodium chloride 0.9% inj BAG</value>
</drugname><strength><value>20 mmol</value>
<value>40 mmol</value>
</strength><frequency><value>CONTINUOUS</value>
<value>ONCE</value>
</frequency><instruction><value>Administer by continuous infusion.</value>
<value>DAY -2. Administer by continuous infusion starting the evening before chemotherapy, run until day 0 post transplant. Then reassess.</value>
<value>DAY 1. Administer 1000 mL over 2 hours. &amp;quot;posthydration&amp;quot;. MAXIMUM RATE: 10 mmol/hour.</value>
<value>DAY 8. Administer 1000 mL over 2 hours. &amp;quot;posthydration&amp;quot;. MAXIMUM RATE: 10 mmol/hour.</value>
<value>DAY 1 of 21. Administer 1000 mL over 2 hours. &amp;quot;posthydration&amp;quot;. MAXIMUM RATE: 10 mmol/hour.</value>
<value>DAY 1 of 21. Administer 1000 mL over 2 hours (posthydration). MAXIMUM RATE: 10 mmol/hour.</value>
<value>DAY 1 of 21. Administer 1000 mL over 2 hours as  prehydration. MAXIMUM RATE: 10 mmol/hour.</value>
<value>DAY 1 of 28. Administer 1000 mL over 2 hours as  prehydration. MAXIMUM RATE: 10 mmol/hour.</value>
<value>DAY 8 of 28. Administer 1000 mL over 2 hours as  prehydration. MAXIMUM RATE: 10 mmol/hour.</value>
</instruction><volume><value>1000 mL</value>
</volume><units><value>mL/hour</value>
</units><additionalnotes><value>May be used as alternative to 1000 mL 0.9% sodium chloride posthydration.</value>
<value>May be used as alternative to 1000 mL 0.9% sodium chloride.</value>
<value>May be used as alternative to 1000 mL 0.9% sodium chloride prehydration.</value>
<value>Requirement  determined by physician.</value>
</additionalnotes><population><value>Adjuvant Vinorelbine/CISplatin (every 28 days). Non-Small Cell Lung Cancer</value>
<value>Adjuvant Vinorelbine/CISplatin (every 21 days). Non-Small Cell Lung Cancer</value>
<value>Pemetrexed/CISplatin. Non-Small Cell Lung Cancer</value>
<value>Vinorelbine / CISplatin. Advanced NSCLC</value>
<value>CISplatin &amp; Vinorelbine with CONCURRENT RT. Non-Small Cell Lung Cancer</value>
<value>Gemcitabine / CISplatin. Non-Small Cell Lung Cancer</value>
<value>CISplatin/etoposide (po). Small Cell Lung Cancer</value>
<value>Pemetrexed / CISplatin. Mesothelioma.</value>
<value>Etoposide (Days 1-5)/CISplatin (Days 1 &amp; 8) with concurrent RT. Pancoast Tumor</value>
</population><indicationprn></indicationprn><backgroundinformation></backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Not a pharmacy product.</value>
</ahsformularystatus><ahfsname><value>Replacement Preparations</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>00786209</value>
<value>00786217</value>
</din></drug>